SCHEMBL112681

SCHEMBL112681

CN1CCN(Cc2ccc3c(c2)ncn3C(=O)O)CC1

nearest known ligand 0.44

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
HDAC6 Q9UBN7 1/20 0.44
CHKA P35790 3/20 0.44
MC4R P32245 1/20 0.43
HTR6 P50406 1/20 0.43
GRM2 Q14416 1/20 0.43
ACHE P22303 1/20 0.42
SIGMAR1 Q99720 3/20 0.41
DRD4 P21917 2/20 0.41
LMNA P02545 1/20 0.41
NPC1 O15118 1/20 0.40
TP53 P04637 1/20 0.40
RAB9A P51151 1/20 0.40
IDO1 P14902 1/20 0.40
TDO2 P48775 1/20 0.40
IDO2 Q6ZQW0 1/20 0.40
CNR2 P34972 1/20 0.40
HRH3 Q9Y5N1 1/20 0.40
FAAH O00519 1/20 0.39
MGLL Q99685 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2130373 0.84 SIGMAR1 (0.41) HDAC6CHKAHTR6GRM2SIGMAR1
SCHEMBL19717080 0.76 ASAH1 (0.40) LMNA
SCHEMBL2143607 0.75 PIK3CD (0.43) HDAC6CHKAIDO1TDO2IDO2
SCHEMBL2320716 0.72 SIGMAR1 (0.58) CHKASIGMAR1DRD4LMNANPC1
SCHEMBL19716710 0.70 FGFR1 (0.53) LMNANPC1TP53RAB9A
SCHEMBL4557635 0.69 HSP90AA1 (0.62) HDAC6CHKAMC4RACHESIGMAR1
SCHEMBL30547807 0.69 KDM4E (0.52) HDAC6CHKAMC4RHTR6FAAH
SCHEMBL17311578 0.69 CHKA (0.53) HDAC6CHKAMC4RHTR6ACHE
SCHEMBL31300692 0.68 ENPP2 (0.48) HDAC6MC4RHTR6ACHELMNA
SCHEMBL6188428 0.68 HDAC6 (0.54) HDAC6CHKAMC4RACHELMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2424843-A1 IMIDAZOLE DERIVATIVES AND THEIR USE AS MODULATORS OF CYCLIN DEPENDENT KINASES Novartis AG (CH) 2012-03-07 EP disclosed
WO-2010125402-A1 IMIDAZOLE DERIVATIVES AND THEIR USE AS MODULATORS OF CYCLIN DEPENDENT KINASES NOVARTIS AG (CH) 2010-11-04 WO disclosed